0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA)

DRUG3 trials

Sponsors

Novo Nordisk A/S

Conditions

HealthyMenopausal Vasomotor SymptomsMenopausePostmenopausal Bleeding

Phase 1

Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women

CompletedNCT01477632

Novo Nordisk A/SHealthy, Menopause

Start: 2005-03-31End: 2005-06-30Updated: 2016-01-15

Phase 3

Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations

CompletedNCT00184795

Novo Nordisk A/SMenopausal Vasomotor Symptoms, Menopause

Start: 2004-05-28End: 2005-05-04Updated: 2017-02-23

Unknown Phase

Observational Study to Investigate the Occurrence of Bleeding in Postmenopausal Women Treated With Estradiol/NETA for 12 Months

CompletedNCT01076621

Novo Nordisk A/SMenopause, Postmenopausal Bleeding

Start: 2010-05-31End: 2013-06-30Updated: 2014-10-27